Kristin Sainani is associate teaching professor of epidemiology and population health at Stanford University in California.
Kristin Sainani
Teaching professor
Stanford University
From this contributor
Journal Club: Meta-analysis oversells popular autism screen
The Modified Checklist for Autism in Toddlers (M-CHAT) accurately flags autistic toddlers, a new systematic review and meta-analysis suggests, contrary to past evidence that the tool’s validity varies depending on a child’s age and traits. Experts weigh in on the discrepancy.
Journal Club: Meta-analysis oversells popular autism screen
By
Spectrum
14 March 2023 | 5 min read
Flawed methods undermine study on undiagnosed autism and suicide
The researchers attempted to retroactively identify signs of autism in people who died by suicide, but their analysis is not convincing.
Flawed methods undermine study on undiagnosed autism and suicide
By
Kristin Sainani
28 February 2022 | 3 min read
Study links screen time to autism, but problems abound
The paper relied on parent-reported data and adjusted for few potentially confounding variables.
Study links screen time to autism, but problems abound
By
Kristin Sainani
1 February 2022 | 4 min read
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
By
Natalia Mesa
3 June 2026 | 11 min read
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
By
Paul Middlebrooks
3 June 2026 | 1 min read
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
By
Calli McMurray
2 June 2026 | 5 min read